Author： Fiasse René Dewit Olivier
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.17, Iss.12, 2007-12, pp. : 1423-1441
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Gut Microbiota in Inflammatory Bowel Disease
Current Pharmaceutical Design, Vol. 15, Iss. 13, 2009-05 ,pp. :
Access to resources
Recommend
Cytokine and Anti-cytokine Therapies for Inflammatory Bowel Disease
Current Pharmaceutical Design, Vol. 9, Iss. 14, 2003-05 ,pp. :
Current Biological Therapies for Inflammatory Bowel Disease
Current Pharmaceutical Design, Vol. 10, Iss. 32, 2004-12 ,pp. :
Novel therapeutics in inflammatory bowel disease
Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 7, 2001-07 ,pp. :
Novel approaches to inflammatory bowel disease
Expert Opinion on Investigational Drugs, Vol. 7, Iss. 7, 1998-07 ,pp. :